Immunodeficiency Diseases Clinical Trials

 

St. Jude Clinical Trials

GENEFU: Long-Term Follow-Up of Patients who have Received Gene Therapy/Gene Marked Products

Eligibility:

This is a non-therapeutic clinical trial that is only open to St. Jude patients.

  • Participant received an integrating retroviral or lentiviral vector based gene transfer or gene marked product at St. Jude Children’s Research Hospital within the past 15 year time period.
View Trial

LVXSCID-ND: Gene Transfer for X-Linked Severe Combined Immunodeficiency (SCID) in Newly Diagnosed Infants

Diseases Treated:

X-linked Severe Combined Immunodeficiency (SCID-X1)

Eligibility:

  • Diagnosis of Severe Combined Immunodeficiency Disease, X-linked (SCID-X1)
  • Newborn to 12 months of age
  • No prior therapy with allogeneic stem cell transplantation
  • No HIV infection
View Trial